HealthQuill Health
Fluorescent staining reveals the extensive network of blood vessels of the dura mater. These vessels contain T cells that, in a mouse model of chronic high blood pressure, become activated and produce conditions that can lead to dementia-like symptoms.Image courtesy of the Iadecola lab.
Drugs Health Pharma

Abnormal brain cell activation in high BP patients linked to dementia

HQ Team December 5, 2023: The response of immune cells inside the protective covering of the brain may lead to a cognitive decline.

Read More
US-based Pacific Northwest National Laboratory, Microsoft Corp., and Micron Technology have joined hands to make computational chemistry available to researchers and industrial users.
Drugs Health Pharma

Roche forays into weight-loss therapy, buys Carmot for $2.7 billion

HQ Team December 4, 2023: In a strategic push into the obesity and diabetes treatment market, Roche, a leading pharmaceutical company, has finalized.

Read More
The COP28 has unveiled a $1.7 billion funding plan to meet climate and diversity goals.
Climate Health Pharma

COP28: $1.7 billion plan to protect climate, diversity goals unveiled

HQ Team December 4, 2023: The COP28 has unveiled a $1.7 billion funding plan to meet climate and diversity goals. The key objectives.

Read More
Eli Lilly and Company got a second accelerated approval from the Food and Drug Administration for its blood cancer drug Jaypirca.
Drugs Health Pharma

Eli Lilly’s drug gets second FDA nod for treating blood cancer in adults

HQ Team December 4, 2023: Eli Lilly and Company got a second accelerated approval from the Food and Drug Administration for its blood.

Read More
Semaglutide based weightloss drugs tied to increased suicide risk in a new study
Drugs Health Pharma

EMA expands probe into suicidal thoughts linked to weight loss drugs

HQ Team December 2, 2023: The European Medicines Agency (EMA) is intensifying its investigation into the potential link between certain GLP-1 receptor agonist.

Read More
A clutch of 41 multilateral development banks, funders, countries and philanthropies announced a global funding plan to cut greenhouse gas emissions and to protect people from climate risks to health.
Climate Health Pharma

COP28: Funding pathway to cut emissions, protect people from risks

HQ Team November 2, 2023: A clutch of 41 multilateral development banks, funders, countries and philanthropies announced a global funding plan to cut.

Read More
Pfizer Inc., has discontinued its clinical trials of the twice-daily oral weight-loss drug, danuglipron, after more than 50% of the patients opted out due to adverse effects of the medicine.
Drugs Health Pharma

Pfizer Inc., stops twice-daily oral obesity drug trial at mid-stage

HQ Team December 2, 2023: Pfizer Inc., has discontinued its clinical trials of the twice-daily oral weight-loss drug, danuglipron, after more than 50%.

Read More
The US Food and Drug Administration (USFDA) is assessing the potential for failures in plastic syringes manufactured in China.
Drugs Health Pharma

FDA probes failure of syringes made in China for possible breakages

HQ Team December 1, 2023: The US Food and Drug Administration (USFDA) is assessing the potential for failures in plastic syringes manufactured in.

Read More
The full year 2023 is set to be the warmest on record with global temperatures rising 1.4 degrees Celsius above pre-industrial levels, as the UN chief called on COP28 nations to set “clear expectations” for climate goals and invest in their implementation. Image Credit: UN
Climate Health Pharma

Record global heat ‘sending shivers down the spines of world leaders’: UN

HQ Team December 1, 2023: The full year 2023 is set to be the warmest on record with global temperatures rising 1.4 degrees.

Read More
AbbVie Inc., operating in therapeutic areas such as immunology, oncology, neuroscience, and eye care, announced a pact to acquire ImmunoGen, Inc., for $10.1 billion. Image Credit: AbbVie
Drugs Health Pharma

AbbVie to buy Immunogen for $10.1b to expand solid tumour market

HQ Team November 30, 2023: AbbVie Inc., operating in therapeutic areas such as immunology, oncology, neuroscience, and eye care, announced a pact to.

Read More